Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers.
Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group.
Başcı S, et al. Among authors: berber i.
Intern Emerg Med. 2022 Jan;17(1):135-139. doi: 10.1007/s11739-021-02784-y. Epub 2021 Jun 10.
Intern Emerg Med. 2022.
PMID: 34110562
Free PMC article.